Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?
Rocket Pharmaceuticals Ownership Summary
Rocket Pharmaceuticals is owned by 90.66% institutional investors, 2.92% insiders, and 6.42% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 18.87% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.14% of its assets in Rocket Pharmaceuticals shares.
RCKT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Rocket Pharmaceuticals | 90.66% | 2.92% | 6.42% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Rtw investments, lp | 17.69M | 18.87% | $380.82M |
Wellington management group llp | 14.00M | 14.86% | $175.92M |
Blackrock funding, inc. /de | 7.10M | 7.54% | $89.21M |
Vanguard group | 6.58M | 6.99% | $82.68M |
Blackrock | 6.19M | 6.61% | $133.33M |
Maverick capital | 5.20M | 5.52% | $65.35M |
Westfield capital management co lp | 4.71M | 5.01% | $59.26M |
Janus henderson group | 4.00M | 4.25% | $50.34M |
Price t rowe associates inc /md/ | 3.15M | 3.34% | $39.58M |
State street | 2.78M | 2.97% | $59.85M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rtw investments, lp | 17.69M | 5.90% | $380.82M |
M28 capital management lp | 385.68K | 4.76% | $4.85M |
New leaf venture partners | 150.71K | 2.53% | $1.89M |
Bioimpact capital | 1.02M | 1.82% | $12.83M |
Acuta capital partners | 134.50K | 1.70% | $1.69M |
Boxer capital | 1.47M | 1.66% | $31.56M |
Frazier life sciences management | 1.56M | 1.57% | $33.61M |
Exome asset management | 159.55K | 1.51% | $2.01M |
Avidity partners management lp | 1.05M | 1.30% | $13.24M |
Privium fund management b.v. | 250.98K | 1.27% | $4.96M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Wellington management group llp | 14.00M | 0.03% | 2.75M |
Suvretta capital management | 2.57M | 1.10% | 2.57M |
Janus henderson group | 4.00M | 0.03% | 2.11M |
Point72 asset management | 1.57M | 0.04% | 1.52M |
Avoro capital advisors | 1.20M | 0.21% | 1.20M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 2.78M | 0.00% | -1.41M |
Franklin resources | 653.56K | 0.00% | -1.08M |
Millennium management | 336.91K | 0.00% | -865.59K |
Bamco inc /ny/ | 75.00K | 0.00% | -809.34K |
First turn management | - | - | -621.31K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Suvretta capital management | 2.57M | 1.10% | 2.57M | $32.27M |
Avoro capital advisors | 1.20M | 0.21% | 1.20M | $15.08M |
Toronto dominion bank | 1.10M | 0.02% | 1.10M | $13.83M |
Siren | 600.00K | 0.33% | 600.00K | $7.54M |
Voss capital | 421.70K | 0.39% | 421.70K | $5.30M |
Sold Out
Holder | Change |
---|---|
Allspring global investments | -20.00 |
Evermay wealth management | -25.00 |
Innealta capital | -49.00 |
Lazard asset management | -78.00 |
Capital analysts | -175.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 215 | 8.59% | 85,361,633 | -7.77% | 90 | 0.94% | 140 | 44.33% | 43 | -20.37% |
Sep 30, 2024 | 198 | 7.03% | 92,550,219 | 1.43% | 98 | 1.04% | 97 | -2.02% | 54 | 10.20% |
Jun 30, 2024 | 185 | -7.04% | 91,245,649 | -1.15% | 97 | 1.00% | 99 | 11.24% | 49 | -23.44% |
Mar 31, 2024 | 199 | -4.78% | 92,305,110 | 3.71% | 98 | 1.09% | 89 | -15.24% | 64 | -5.88% |
Dec 31, 2023 | 209 | 11.17% | 89,005,181 | -0.46% | 95 | 0.81% | 105 | -5.41% | 68 | 54.55% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Health Care Inv | 7.60M | 7.14% | 1.11M |
Vanguard Total Stock Mkt Idx Inv | 2.62M | 2.46% | - |
RTW Biotech Opportunities Ord | 2.40M | 2.25% | - |
Vanguard US Total Market Shares ETF | 2.21M | 2.08% | -245.50K |
iShares Russell 2000 ETF | 2.01M | 1.89% | -17.43K |
SPDR® S&P Biotech ETF | 1.91M | 1.79% | -20.47K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.29M | 1.21% | 2.56K |
Westfield Capital Mgt Co Sm-Cap Gr Eq | 1.23M | 1.16% | 22.76K |
Harbor Small Cap Growth Instl | 1.23M | 1.16% | 22.76K |
Vanguard Small Cap Index | 1.07M | 1.00% | 861.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 09, 2025 | Patel Kinnari | See Remarks | Buy | - |
Apr 04, 2025 | Ondrey Aaron | Chief Financial Officer | Sell | $39.65K |
May 17, 2024 | Schwartz Jonathan David | See Remarks | Sell | $64.31K |
Feb 25, 2025 | Schwartz Jonathan David | See Remarks | Sell | $69.11K |
Aug 16, 2024 | Schwartz Jonathan David | See Remarks | Sell | $50.13K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 1 | 1 |
2025 Q1 | - | 6 |
2024 Q3 | - | 6 |
2024 Q2 | - | 9 |
2024 Q1 | - | 9 |
RCKT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools